Zyxin cooperates with PTOV1 to confer retinoic acid resistance by repressing RAR activity

Cancer Letters

Volumn 331, Issue 2, 2013, Pages 192-199

  Youn, HyeSook ^a   Kim, Eun Joo ^b   Um, Soo Jong ^a  

^a Sejong University   (South Korea)

^b Dankook University   (South Korea)

Author keywords

Cancer; PTOV1; RA resistance; RAR; Zyxin

Indexed keywords

HISTONE ACETYLTRANSFERASE PCAF; PTOV1 PROTEIN; RETINOIC ACID; RETINOIC ACID RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG; ZYXIN;

ARTICLE; CANCER CELL; CANCER RESISTANCE; CELL NUCLEUS; CELLULAR DISTRIBUTION; COMPLEX FORMATION; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; GENE REPRESSION; LIM DOMAIN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

BASE SEQUENCE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; DNA PRIMERS; FLOW CYTOMETRY; HUMANS; MICROSCOPY, FLUORESCENCE; NEOPLASM PROTEINS; PROTEIN BINDING; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, RETINOIC ACID; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRETINOIN; TUMOR MARKERS, BIOLOGICAL; ZYXIN;

EID: 84875370599     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.12.019     Document Type: Article

References (35)

1. Gudas L.J., Sporn M.B., Roberts A.B. Cellular biology and biochemistry of the retinoids. The Retinoids: Biology, Chemistry and Medicine 1994, 443-520. Raven Press, New York. second ed. M.B. Sporn, A.B. Roberts, D.S. Goodman (Eds.).
2. Noy N. Between death and survival: retinoic acid in regulation of apoptosis. Annu. Rev. Nutr. 2010, 30:201-217.
3. Simoni D., Tolomeo M. Retinoids, apoptosis and cancer. Curr. Pharm. Des. 2001, 7:1823-1837.
4. Altucci L., Gronemeyer H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer 2001, 1:181-193.
5. Chambon P. The molecular and genetic dissection of the retinoid signaling pathway. Recent Prog. Horm. Res. 1995, 50:317-332.
6. Glass C.K., Rosenfeld M.G. The coregulator exchange in transcriptional functions of nuclear receptors. Genes Dev. 2000, 14:121-141.
7. Nettles K.W., Greene G.L. Ligand control of coregulator recruitment to nuclear receptors. Annu. Rev. Physiol. 2005, 67:309-333.
8. O'Malley B.W. The Year in Basic Science: nuclear receptors and coregulators. Mol. Endocrinol. 2008, 22:2751-2758.
9. Chen W., Roeder R.G. Mediator-dependent nuclear receptor function. Semin. Cell Dev. Biol. 2011, 22:749-758.
10. Mittler G., Stuhler T., Santolin L., Uhlmann T., Kremmer E., Lottspeich F., Berti L., Meisterernst M. A novel docking site on Mediator is critical for activation by VP16 in mammalian cells. EMBO J. 2003, 22:6494-6504.
11. Yang F., DeBeaumont R., Zhou S., Näär A.M. The activator-recruited cofactor/Mediator coactivator subunit ARC92 is a functionally important target of the VP16 transcriptional activator. Proc. Natl. Acad. Sci. USA 2004, 101:2339-2344.
12. Lee H.K., Park U.H., Kim E.J., Um S.J. MED25 is distinct from TRAP220/MED1 in cooperating with CBP for retinoid receptor activation. EMBO J. 2007, 26:3545-3557.
13. Youn H.S., Park U.H., Kim E.J., Um S.J. PTOV1 antagonizes MED25 in RAR transcriptional activation. Biochem. Biophys. Res. Commun. 2011, 404:239-244.
14. Santamaria A., Castellanos E., Gomez V., Benedit P., Renau-Piqueras J., Morote J., Reventós J., Thomson T.M., Paciucci R. PTOV1 enables the nuclear translocation and mitogenic activity of flotillin-1, a major protein of lipid rafts. Mol. Cell. Biol. 2005, 25:1900-1911.
15. Nakamura Y., Suzuki T., Igarashi K., Kanno J., Furukawa T., Tazawa C., Fujishima F., Miura I., Ando T., Moriyama N., Moriya T., Saito H., Yamada S., Sasano H. PTOV1: a novel testosterone-induced atherogenic gene in human aorta. J. Pathol. 2006, 209:522-531.
16. Morote J., Fernandez S., Alana L., Iglesias C., Planas J., Reventós J., Ramón Y., Cajal S., Paciucci R., de Torres I.M. PTOV1 expression predicts prostate cancer in men with isolated high-grade prostatic intraepithelial neoplasia in needle biopsy. Clin. Cancer Res. 2008, 14:2617-2622.
17. Beckerle M.C. Zyxin: zinc fingers at sites of cell adhesion. Bioessays 1997, 19:949-957.
18. Wang Y., Gilmore T.D. Zyxin and paxillin proteins: focal adhesion plaque LIM domain proteins go nuclear. Biochim. Biophys. Acta 2003, 1593:115-120.
19. Goyal R.K., Lin P., Kanungo J., Payne A.S., Muslin A.J., Longmore G.D. Ajuba, a novel LIM protein, interacts with Grb2, augments mitogen activated protein kinase activity in fibroblasts, and promotes meiotic maturation of Xenopus oocytes in a Grb2- and Ras-dependent manner. Mol. Cell. Biol. 1999, 19:4379-4389.
20. Hou Z., Peng H., White D.E., Negorev D.G., Maul G.G., Feng Y., Longmore G.D., Waxman S., Zelent A., Rauscher F.J. LIM protein Ajuba functions as a nuclear receptor corepressor and negatively regulates retinoic acid signaling. Proc. Natl. Acad. Sci. USA 2010, 107:2938-2943.
21. Fujita Y., Yamaguchi A., Hata K., Endo M., Yamaguchi N., Yamashita T. Zyxin is a novel interacting partner for SIRT1. BMC Cell Biol. 2009, 10:6.
22. Chan C.B., Liu X., Tang X., Fu H., Ye K. Akt phosphorylation of Zyxin mediates its interaction with acinus-S and prevents acinus-triggered chromatin condensation. Cell Death Differ. 2007, 14:1688-1699.
23. Degenhardt Y.Y., Silverstein S. Interaction of Zyxin, a focal adhesion protein, with the e6 protein from human papillomavirus type 6 results in its nuclear translocation. J. Virol. 2001, 75:11791-11802.
24. Cho Y.S., Kim E.J., Park U.H., Sin H.S., Um S.J. Additional sex comb-like 1 (ASXL1), in cooperation with SRC-1, acts as a ligand-dependent coactivator for retinoic acid receptor. J. Biol. Chem. 2006, 281:17588-17598.
25. Sun S.Y., Lotan R. Retinoids and their receptors in cancer development and chemoprevention. Crit. Rev. Oncol. Hematol. 2002, 41:41-55.
26. Teraishi F., Kadowaki Y., Tango Y., Kawashima T., Umeoka T., Kagawa S., Tanaka N., Fujiwara T. Ectopic p21sdi1 gene transfer induces retinoic acid receptor beta expression and sensitizes human cancer cells to retinoid treatment. Int. J. Cancer 2003, 103:833-839.
27. Fondell J.D., Ge H., Roeder R.G. Ligand induction of a transcriptionally active thyroid hormone receptor coactivator complex. Proc. Natl. Acad. Sci. USA 1996, 93:8329-8333.
28. Zhu Y., Qi C., Jain S., Rao M.S., Reddy J.K. Isolation and characterization of PBP, a protein that interacts with peroxisome proliferator-activated receptor. J. Biol. Chem. 1997, 272:25500-25506.
29. Rachez C., Lemon B.D., Suldan Z., Bromleigh V., Gamble M. Ligand-dependent transcription activation by nuclear receptors requires the DRIP complex. Nature 1999, 398:824-828.
30. Wang Q., Sharma D., Ren Y., Fondell J.D. A coregulatory role for the TRAP-mediator complex in androgen receptor-mediated gene expression. J. Biol. Chem. 2002, 277:42852-42858.
31. Chakravarti D., LaMorte V.J., Nelson M.C., Nakajima T., Schulman I.G., Juguilon H., Montminy M., Evans R.M. Role of CBP/P300 in nuclear receptor signaling. Nature 1996, 383:99-103.
32. Santamaria A., Fernandez P.L., Farre X., Benedit P., Reventós J., Morote J., Paciucci R., Thomson T.M. PTOV-1, a novel protein overexpressed in prostate cancer, shuttles between the cytoplasm and the nucleus and promotes entry into the S phase of the cell division cycle. Am. J. Pathol. 2003, 162:897-905.
33. Masia S., Alvarez S., de Lera A.R., Barettino D. Rapid, nongenomic actions of retinoic acid on phosphatidylinositol-3-kinase signaling pathway mediated by the retinoic acid receptor. Mol. Endocrinol. 2007, 21:2391-2402.
34. Ohashi E., Kogai T., Kagechika H., Brent G.A. Activation of the PI3 kinase pathway by retinoic acid mediates sodium/iodide symporter induction and iodide transport in MCF-7 breast cancer cells. Cancer Res. 2009, 69:3443-3450.
35. Dietze E.C., Troch M.M., Bowie M.L., Yee L., Bean G.R., Seewaldt V.L. CBP/p300 induction is required for retinoic acid sensitivity in human mammary cells. Biochem. Biophys. Res. Commun. 2003, 302:841-848.